[1]
Zhang L, Vijg J. Somatic Mutagenesis in Mammals and Its Implications for Human Disease and Aging. Annual review of genetics. 2018 Nov 23:52():397-419. doi: 10.1146/annurev-genet-120417-031501. Epub 2018 Sep 13
[PubMed PMID: 30212236]
[2]
Cooper DN. Human gene mutation in pathology and evolution. Journal of inherited metabolic disease. 2002 May:25(3):157-82
[PubMed PMID: 12137225]
[3]
Ayatollahi H, Keramati MR, Shirdel A, Kooshyar MM, Raiszadeh M, Shakeri S, Sadeghian MH. BCR-ABL fusion genes and laboratory findings in patients with chronic myeloid leukemia in northeast Iran. Caspian journal of internal medicine. 2018 Winter:9(1):65-70. doi: 10.22088/cjim.9.1.65. Epub
[PubMed PMID: 29387322]
[4]
Ribeil JA,Hacein-Bey-Abina S,Payen E,Magnani A,Semeraro M,Magrin E,Caccavelli L,Neven B,Bourget P,El Nemer W,Bartolucci P,Weber L,Puy H,Meritet JF,Grevent D,Beuzard Y,Chrétien S,Lefebvre T,Ross RW,Negre O,Veres G,Sandler L,Soni S,de Montalembert M,Blanche S,Leboulch P,Cavazzana M, Gene Therapy in a Patient with Sickle Cell Disease. The New England journal of medicine. 2017 Mar 2
[PubMed PMID: 28249145]
[5]
McHugh DR, Steele MS, Valerio DM, Miron A, Mann RJ, LePage DF, Conlon RA, Cotton CU, Drumm ML, Hodges CA. A G542X cystic fibrosis mouse model for examining nonsense mutation directed therapies. PloS one. 2018:13(6):e0199573. doi: 10.1371/journal.pone.0199573. Epub 2018 Jun 20
[PubMed PMID: 29924856]
[6]
Tabebordbar M, Zhu K, Cheng JKW, Chew WL, Widrick JJ, Yan WX, Maesner C, Wu EY, Xiao R, Ran FA, Cong L, Zhang F, Vandenberghe LH, Church GM, Wagers AJ. In vivo gene editing in dystrophic mouse muscle and muscle stem cells. Science (New York, N.Y.). 2016 Jan 22:351(6271):407-411. doi: 10.1126/science.aad5177. Epub 2015 Dec 31
[PubMed PMID: 26721686]
[7]
Atweh GF, Anagnou NP, Shearin J, Forget BG, Kaufman RE. Beta-thalassemia resulting from a single nucleotide substitution in an acceptor splice site. Nucleic acids research. 1985 Feb 11:13(3):777-90
[PubMed PMID: 2987809]
[8]
Lenski RE. What is adaptation by natural selection? Perspectives of an experimental microbiologist. PLoS genetics. 2017 Apr:13(4):e1006668. doi: 10.1371/journal.pgen.1006668. Epub 2017 Apr 20
[PubMed PMID: 28426692]
Level 3 (low-level) evidence
[9]
Kunkel TA. Evolving views of DNA replication (in)fidelity. Cold Spring Harbor symposia on quantitative biology. 2009:74():91-101. doi: 10.1101/sqb.2009.74.027. Epub 2009 Nov 10
[PubMed PMID: 19903750]
[10]
Chatterjee N, Walker GC. Mechanisms of DNA damage, repair, and mutagenesis. Environmental and molecular mutagenesis. 2017 Jun:58(5):235-263. doi: 10.1002/em.22087. Epub 2017 May 9
[PubMed PMID: 28485537]
[11]
Heidenreich E, Novotny R, Kneidinger B, Holzmann V, Wintersberger U. Non-homologous end joining as an important mutagenic process in cell cycle-arrested cells. The EMBO journal. 2003 May 1:22(9):2274-83
[PubMed PMID: 12727893]
[12]
De Bont R, van Larebeke N. Endogenous DNA damage in humans: a review of quantitative data. Mutagenesis. 2004 May:19(3):169-85
[PubMed PMID: 15123782]
[13]
Chan K, Resnick MA, Gordenin DA. The choice of nucleotide inserted opposite abasic sites formed within chromosomal DNA reveals the polymerase activities participating in translesion DNA synthesis. DNA repair. 2013 Nov:12(11):878-89. doi: 10.1016/j.dnarep.2013.07.008. Epub 2013 Aug 26
[PubMed PMID: 23988736]
[14]
Shen X, Li L. Mutagenic repair of DNA interstrand crosslinks. Environmental and molecular mutagenesis. 2010 Jul:51(6):493-9. doi: 10.1002/em.20558. Epub
[PubMed PMID: 20209624]
[15]
Ranzani M, Annunziato S, Adams DJ, Montini E. Cancer gene discovery: exploiting insertional mutagenesis. Molecular cancer research : MCR. 2013 Oct:11(10):1141-58. doi: 10.1158/1541-7786.MCR-13-0244. Epub 2013 Aug 8
[PubMed PMID: 23928056]
[16]
Carlson ES, Upadhyaya P, Hecht SS. A General Method for Detecting Nitrosamide Formation in the In Vitro Metabolism of Nitrosamines by Cytochrome P450s. Journal of visualized experiments : JoVE. 2017 Sep 25:(127):. doi: 10.3791/56312. Epub 2017 Sep 25
[PubMed PMID: 28994777]
[17]
Ling MM, Robinson BH. Approaches to DNA mutagenesis: an overview. Analytical biochemistry. 1997 Dec 15:254(2):157-78
[PubMed PMID: 9417773]
Level 3 (low-level) evidence
[18]
Bachman J. Site-directed mutagenesis. Methods in enzymology. 2013:529():241-8. doi: 10.1016/B978-0-12-418687-3.00019-7. Epub
[PubMed PMID: 24011050]
[19]
Behjati S, Tarpey PS. What is next generation sequencing? Archives of disease in childhood. Education and practice edition. 2013 Dec:98(6):236-8. doi: 10.1136/archdischild-2013-304340. Epub 2013 Aug 28
[PubMed PMID: 23986538]
[20]
Stottmann R, Beier D. ENU Mutagenesis in the Mouse. Current protocols in human genetics. 2014 Jul 14:82():15.4.1-15.4.10. doi: 10.1002/0471142905.hg1504s82. Epub 2014 Jul 14
[PubMed PMID: 25042716]
[21]
Hryhorowicz M, Lipiński D, Zeyland J, Słomski R. CRISPR/Cas9 Immune System as a Tool for Genome Engineering. Archivum immunologiae et therapiae experimentalis. 2017 Jun:65(3):233-240. doi: 10.1007/s00005-016-0427-5. Epub 2016 Oct 3
[PubMed PMID: 27699445]
[22]
Hegazy WA, Youns M. TALENs Construction: Slowly but Surely. Asian Pacific journal of cancer prevention : APJCP. 2016:17(7):3329-34
[PubMed PMID: 27509972]
[23]
Jabalameli HR, Zahednasab H, Karimi-Moghaddam A, Jabalameli MR. Zinc finger nuclease technology: advances and obstacles in modelling and treating genetic disorders. Gene. 2015 Mar 1:558(1):1-5. doi: 10.1016/j.gene.2014.12.044. Epub 2014 Dec 20
[PubMed PMID: 25536166]
Level 3 (low-level) evidence
[24]
Basu AK. DNA Damage, Mutagenesis and Cancer. International journal of molecular sciences. 2018 Mar 23:19(4):. doi: 10.3390/ijms19040970. Epub 2018 Mar 23
[PubMed PMID: 29570697]
[25]
Tomasetti C, Li L, Vogelstein B. Stem cell divisions, somatic mutations, cancer etiology, and cancer prevention. Science (New York, N.Y.). 2017 Mar 24:355(6331):1330-1334. doi: 10.1126/science.aaf9011. Epub
[PubMed PMID: 28336671]
[26]
Andreotti G, Freedman ND, Silverman DT, Lerro CC, Koutros S, Hartge P, Alavanja MC, Sandler DP, Freeman LB. Tobacco Use and Cancer Risk in the Agricultural Health Study. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2017 May:26(5):769-778. doi: 10.1158/1055-9965.EPI-16-0748. Epub 2016 Dec 29
[PubMed PMID: 28035020]
[27]
Sarasin A, Bounacer A, Lepage F, Schlumberger M, Suarez HG. Mechanisms of mutagenesis in mammalian cells. Application to human thyroid tumours. Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie. 1999 Feb-Mar:322(2-3):143-9
[PubMed PMID: 10196666]
[28]
Szikriszt B, Póti Á, Pipek O, Krzystanek M, Kanu N, Molnár J, Ribli D, Szeltner Z, Tusnády GE, Csabai I, Szallasi Z, Swanton C, Szüts D. A comprehensive survey of the mutagenic impact of common cancer cytotoxics. Genome biology. 2016 May 9:17():99. doi: 10.1186/s13059-016-0963-7. Epub 2016 May 9
[PubMed PMID: 27161042]
Level 3 (low-level) evidence
[29]
Naik RP, Haywood C Jr. Sickle cell trait diagnosis: clinical and social implications. Hematology. American Society of Hematology. Education Program. 2015:2015(1):160-7. doi: 10.1182/asheducation-2015.1.160. Epub
[PubMed PMID: 26637716]
[30]
Meremikwu MM, Okomo U. Sickle cell disease. BMJ clinical evidence. 2016 Jan 22:2016():. pii: 2402. Epub 2016 Jan 22
[PubMed PMID: 26808098]
[31]
Munita JM, Arias CA. Mechanisms of Antibiotic Resistance. Microbiology spectrum. 2016 Apr:4(2):. doi: 10.1128/microbiolspec.VMBF-0016-2015. Epub
[PubMed PMID: 27227291]
[32]
Campos MC, Phelan J, Francisco AF, Taylor MC, Lewis MD, Pain A, Clark TG, Kelly JM. Genome-wide mutagenesis and multi-drug resistance in American trypanosomes induced by the front-line drug benznidazole. Scientific reports. 2017 Oct 31:7(1):14407. doi: 10.1038/s41598-017-14986-6. Epub 2017 Oct 31
[PubMed PMID: 29089615]
[33]
Smits P, Bolton AD, Funari V, Hong M, Boyden ED, Lu L, Manning DK, Dwyer ND, Moran JL, Prysak M, Merriman B, Nelson SF, Bonafé L, Superti-Furga A, Ikegawa S, Krakow D, Cohn DH, Kirchhausen T, Warman ML, Beier DR. Lethal skeletal dysplasia in mice and humans lacking the golgin GMAP-210. The New England journal of medicine. 2010 Jan 21:362(3):206-16. doi: 10.1056/NEJMoa0900158. Epub
[PubMed PMID: 20089971]
[34]
Wang X. Gene mutation-based and specific therapies in precision medicine. Journal of cellular and molecular medicine. 2016 Apr:20(4):577-80. doi: 10.1111/jcmm.12722. Epub
[PubMed PMID: 26994883]
[35]
Redman M, King A, Watson C, King D. What is CRISPR/Cas9? Archives of disease in childhood. Education and practice edition. 2016 Aug:101(4):213-5. doi: 10.1136/archdischild-2016-310459. Epub 2016 Apr 8
[PubMed PMID: 27059283]